FH-006

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for FH-006, covering 2025-08-22 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer [Phase 2]

See pricing